Compare Organon Pharma Indonesia Tbk. (SCPI) vs Siloam International Hospitals Tbk. (SILO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Organon Pharma Indonesia Tbk. vs Siloam International Hospitals Tbk. — how do they compare? Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B), while Siloam International Hospitals Tbk. trades at Rp2,010 (market cap 26.53T, 613.6K 24h volume). The key difference: Siloam International Hospitals Tbk. is far larger — about 254.1× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| SCPI | SILO | |
|---|---|---|
Market Cap | 104.4B | 26.53T |
Volume | — | 613.6K |
Lot | — | 6.14K |
Turnover | — | 1.24B |
Average Price | — | 2,017.65 |
Value | — | 1.24B |
Indicative Equilibrium Price | — | 2,010 |
Indicative Equilibrium Volume | — | 73 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →About Siloam International Hospitals Tbk.
PT Siloam International Hospitals Tbk (the Company) was established under its original name of PT Sentralindo Wirasta on August 3, 1996. The Company started commercial operations in 2010 after the restructuring of the hospital unit of PT Lippo Karawaci Tbk.
Read more on SILO →
